IKT · Inhibikase Therapeutics, Inc. · Congressional Trades
$1.53
-0.10 (-6.13%)
At close · Nov 12
Return incl. dividend (before tax)
Q2 2024 earnings call transcript
Market Cap
$214.61M
Shares
140.27M
Volume · Nov 12
728.31K
Avg daily vol (3M)
566.38K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.
Key facts
CIK
1750149
CUSIP
45719W205
13F (30d)
48 filings
45 filers
Visit website
Investor relations